NDC 0078-0494

TOBI

Tobramycin

TOBI is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Tobramycin.

Product ID0078-0494_cb71e4dc-f6a7-455f-b72c-78cb8a4d3fee
NDC0078-0494
Product TypeHuman Prescription Drug
Proprietary NameTOBI
Generic NameTobramycin
Dosage FormSolution
Route of AdministrationORAL
Marketing Start Date1997-12-22
Marketing CategoryNDA / NDA
Application NumberNDA050753
Labeler NameNovartis Pharmaceuticals Corporation
Substance NameTOBRAMYCIN
Active Ingredient Strength300 mg/5mL
Pharm ClassesAminoglycoside Antibacterial [EPC],Aminoglycosides [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0078-0494-71

56 POUCH in 1 CARTON (0078-0494-71) > 4 AMPULE in 1 POUCH (0078-0494-91) > 5 mL in 1 AMPULE (0078-0494-61)
Marketing Start Date1997-12-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0078-0494-91 [00078049491]

TOBI SOLUTION
Marketing CategoryNDA
Application NumberNDA050753
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-07-02

NDC 0078-0494-61 [00078049461]

TOBI SOLUTION
Marketing CategoryNDA
Application NumberNDA050753
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1997-12-22

NDC 0078-0494-71 [00078049471]

TOBI SOLUTION
Marketing CategoryNDA
Application NumberNDA050753
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1997-12-22

Drug Details

Active Ingredients

IngredientStrength
TOBRAMYCIN300 mg/5mL

OpenFDA Data

SPL SET ID:94f9e516-6bf6-4e30-8dde-8833c25c2560
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 213194
  • 348719
  • Pharmacological Class

    • Aminoglycoside Antibacterial [EPC]
    • Aminoglycosides [CS]
    • Aminoglycoside Antibacterial [EPC]
    • Aminoglycosides [CS]

    NDC Crossover Matching brand name "TOBI" or generic name "Tobramycin"

    NDCBrand NameGeneric Name
    0078-0494TOBITobramycin
    10122-820BETHKIStobramycin
    0078-0630TOBI PodhalerTobramycin
    0093-3750TobramycinTobramycin
    0093-4085TobramycinTobramycin
    0404-7196TobramycinTobramycin
    0409-3578TOBRAMYCINTOBRAMYCIN
    0703-9402TobramycinTobramycin
    0781-7171TobramycinTobramycin
    10544-883TobramycinTobramycin
    13985-604TobramycinTobramycin
    13985-743TobramycinTobramycin
    17478-290TobramycinTobramycin
    17478-340TobramycinTobramycin
    0065-0643Tobrextobramycin
    0065-0644TOBREXtobramycin
    0078-0813TOBREXtobramycin

    Trademark Results [TOBI]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    TOBI
    TOBI
    98829213 not registered Live/Pending
    Tobi, Inc.
    2024-10-30
    TOBI
    TOBI
    97669601 not registered Live/Pending
    SCSE HOME LLC
    2022-11-09
    TOBI
    TOBI
    90784685 not registered Live/Pending
    HCW Biologics, Inc.
    2021-06-21
    TOBI
    TOBI
    90123270 not registered Live/Pending
    Wei, Chao
    2020-08-19
    TOBI
    TOBI
    88847929 not registered Live/Pending
    MGA Entertainment, Inc.
    2020-03-25
    TOBI
    TOBI
    85931463 not registered Dead/Abandoned
    Novartis AG
    2013-05-14
    TOBI
    TOBI
    85746006 4983442 Live/Registered
    Little Airplane Productions, Inc.
    2012-10-04
    TOBI
    TOBI
    85170184 4028028 Dead/Cancelled
    The Oncology Business Institute
    2010-11-05
    TOBI
    TOBI
    85145153 4488766 Live/Registered
    BGP PRODUCTS OPERATIONS GMBH
    2010-10-05
    TOBI
    TOBI
    79352748 not registered Live/Pending
    Nicole Bongartz
    2022-09-16
    TOBI
    TOBI
    78857304 3280946 Live/Registered
    TOBI PRODUCTS, INC.
    2006-04-09
    TOBI
    TOBI
    78434648 3406527 Live/Registered
    Tobi, LLC
    2004-06-14

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.